Israel News App
Lundbeck’s bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies
Written by
admin
in
6. Business
Accelerated pathway underscores urgent need for innovative solutions for patients with devastating, childhood-onset epilepsies
Novel 5HT2C mechanism designed to reduce…
Continue Reading